MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia

被引:95
作者
Ferracin, Manuela [1 ]
Zagatti, Barbara [1 ]
Rizzotto, Lara [2 ]
Cavazzini, Francesco [2 ]
Veronese, Angelo [1 ]
Ciccone, Maria [2 ]
Saccenti, Elena [1 ,2 ]
Lupini, Laura [1 ]
Grilli, Andrea [1 ]
De Angeli, Cristiano [2 ]
Negrini, Massimo [1 ]
Cuneo, Antonio [2 ]
机构
[1] Univ Ferrara, Dipartimento Med Sperimentale & Diagnost, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dipartimento Sci Biomed & Terapie Avanzate, I-44100 Ferrara, Italy
关键词
DOWN-REGULATION; CANCER-CELLS; PLUS CYCLOPHOSPHAMIDE; TUMOR-SUPPRESSOR; EXPRESSION; APOPTOSIS; RESISTANCE; PROGNOSIS; MIR-221; TARGETS;
D O I
10.1186/1476-4598-9-123
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Background: Fludarabine, is one of the most active single agents in the treatment of chronic lymphocytic leukemia (CLL). Over time, however, virtually all CLL patients become fludarabine-refractory. To elucidate whether microRNAs are involved in the development of fludarabine resistance, we analyzed the expression of 723 human miRNAs before and 5-days after fludarabine mono-therapy in 17 CLL patients which were classified as responder or refractory to fludarabine treatment based on NCI criteria. Results: By comparing the expression profiles of these two groups of patients, we identified a microRNA signature able to distinguish refractory from sensitive CLLs. The expression of some microRNAs was also able to predict fludarabine resistance of 12 independent CLL patients. Among the identified microRNAs, miR-148a, miR-222 and miR-21 exhibited a significantly higher expression in non-responder patients either before and after fludarabine treatment. After performing messenger RNA expression profile of the same patients, the activation of p53-responsive genes was detected in fludarabine responsive cases only, therefore suggesting a possible mechanism linked to microRNA deregulation in non-responder patients. Importantly, inhibition of miR-21 and miR-222 by anti-miRNA oligonucleotides induced a significant increase in caspase activity in fludarabine-treated p53-mutant MEG-01 cells, suggesting that miR-21 and miR-222 up-regulation may be involved in the establishment of fludarabine resistance. Conclusions: This is the first report that reveals the existence of a microRNA profile that differentiate refractory and sensitive CLLs, either before and after fludarabine mono-therapy. A p53 dysfunctional pathway emerged in refractory CLLs and could contribute in explaining the observed miRNA profile. Moreover, this work indicates that specific microRNAs can be used to predict fludarabine resistance and may potentially be used as therapeutic targets, therefore establishing an important starting point for future studies.
引用
收藏
页数:15
相关论文
共 54 条
[1]
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives [J].
Aqeilan, R. I. ;
Calin, G. A. ;
Croce, C. M. .
CELL DEATH AND DIFFERENTIATION, 2010, 17 (02) :215-220
[2]
MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[3]
MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]
Bergmann MA, 2005, HAEMATOLOGICA, V90, P1357
[5]
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[6]
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia [J].
Calin, GA ;
Ferracin, M ;
Cimmino, A ;
Di Leva, G ;
Shimizu, M ;
Wojcik, SE ;
Iorio, MV ;
Visone, R ;
Sever, NI ;
Fabbri, M ;
Iuliano, R ;
Palumbo, T ;
Pichiorri, F ;
Roldo, C ;
Garzon, R ;
Sevignani, C ;
Rassenti, L ;
Alder, H ;
Volinia, S ;
Liu, CG ;
Kipps, TJ ;
Negrini, M ;
Croce, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1793-1801
[7]
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias [J].
Calin, GA ;
Liu, CG ;
Sevignani, C ;
Ferracin, M ;
Felli, N ;
Dumitru, CD ;
Shimizu, M ;
Cimmino, A ;
Zupo, S ;
Dono, M ;
Dell'Aquila, ML ;
Alder, H ;
Rassenti, L ;
Kipps, TJ ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) :11755-11760
[8]
MiR-15a and miR-16-1 cluster functions in human leukemia [J].
Calin, George A. ;
Cimmino, Amelia ;
Fabbri, Muller ;
Ferracin, Manuela ;
Wojcik, Sylwia E. ;
Shimizu, Masayoshi ;
Taccioli, Cristian ;
Zanesi, Nicola ;
Garzon, Ramiro ;
Aqeilan, Rami I. ;
Alder, Hansjuerg ;
Volinia, Stefano ;
Rassenti, Laura ;
Liu, Xiuping ;
Liu, Chang-gong ;
Kipps, Thomas J. ;
Negrini, Massimo ;
Croce, Carlo M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (13) :5166-5171
[9]
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial [J].
Catovsky, D. ;
Richards, S. ;
Matutes, E. ;
Oscier, D. ;
Dyer, M. J. S. ;
FBezares, R. ;
Pettitt, A. R. ;
Hamblin, T. ;
Milligan, D. W. ;
Child, J. A. ;
Hamilton, M. S. ;
Dearden, C. E. ;
Smith, A. G. ;
Bosanquet, A. G. ;
Davis, Z. ;
Brito-Babapulle, V. ;
Else, M. ;
Wade, R. ;
Hillmen, P. .
LANCET, 2007, 370 (9583) :230-239
[10]
CAVAZZINI F, 2008, BRIT J HAEMATOL, V529, P14